Trial Profile
A Phase 1 Trial of Verteporfin Photodynamic Therapy in Unresectable Pancreatic Carcinoma (VERTPAC-01 study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jul 2020
Price :
$35
*
At a glance
- Drugs Verteporfin (Primary)
- Indications Carcinoma; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms VERTPAC-01
- 19 May 2020 Preliminary results presented at the Digestive Disease Week 2020.
- 28 Jul 2017 New trial record